Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth C Anderson

Showing results (191-200 of 868) with videos related to

Pageof 87
Sort By:
International Journal of Hematology|November 15, 2002
Novel biologically based therapies for multiple myelomaNikhil C Munshi, Teru Hideshima, Dharminder Chauhan, et al.
Best Practice & Research. Clinical Haematology|December 12, 2007
The malignant clone and the bone-marrow environmentKlaus Podar, Paul G Richardson, Teru Hideshima, et al.
Frontiers in Oncology|November 4, 2022
Bispecific antibodies in multiple myeloma treatment: A journey in progressShih-Feng Cho, Tsung-Jang Yeh, Kenneth C Anderson, et al.
Expert Review of Hematology|December 20, 2013
Future agents and treatment directions in multiple myelomaEnrique M Ocio, Constantine S Mitsiades, Robert Z Orlowski, et al.
Expert Opinion on Drug Metabolism & Toxicology|April 20, 2012
Perifosine , an oral, anti-cancer agent and inhibitor of the Akt pathway: mechanistic actions, pharmacodynamics, pharmacokinetics, and clinical activityPaul G Richardson, Cathy Eng, Jill Kolesar, et al.
Analytical Chemistry|March 12, 2014
A nano ultra-performance liquid chromatography-high resolution mass spectrometry approach for global metabolomic profiling and case study on drug-resistant multiple myelomaDrew R Jones, Zhiping Wu, Dharminder Chauhan, et al.
Leukemia|March 16, 2019
Selective targeting of multiple myeloma by B cell maturation antigen (BCMA)-specific central memory CD8<sup>+</sup> cytotoxic T lymphocytes: immunotherapeutic application in vaccination and adoptive immunotherapyJooeun Bae, Mehmet Samur, Paul Richardson, et al.
Current Opinion in Hematology|September 28, 2007
Novel therapies in myelomaPatrick J Hayden, Constantine S Mitsiades, Kenneth C Anderson, et al.
Nature Clinical Practice. Oncology|May 31, 2007
Does maintenance therapy with thalidomide benefit patients with multiple myeloma?Nikhil C Munshi, Constantine S Mitsiades, Paul G Richardson, et al.
Lancet (London, England)|June 23, 2009
Multiple myelomaMarc S Raab, Klaus Podar, Iris Breitkreutz, et al.
Pageof 87

Showing results (191-200 of 868) with videos related to

Sort By:
Pageof 87
International Journal of Hematology|November 15, 2002
Novel biologically based therapies for multiple myelomaNikhil C Munshi, Teru Hideshima, Dharminder Chauhan, et al.
Best Practice & Research. Clinical Haematology|December 12, 2007
The malignant clone and the bone-marrow environmentKlaus Podar, Paul G Richardson, Teru Hideshima, et al.
Frontiers in Oncology|November 4, 2022
Bispecific antibodies in multiple myeloma treatment: A journey in progressShih-Feng Cho, Tsung-Jang Yeh, Kenneth C Anderson, et al.
Expert Review of Hematology|December 20, 2013
Future agents and treatment directions in multiple myelomaEnrique M Ocio, Constantine S Mitsiades, Robert Z Orlowski, et al.
Expert Opinion on Drug Metabolism & Toxicology|April 20, 2012
Perifosine , an oral, anti-cancer agent and inhibitor of the Akt pathway: mechanistic actions, pharmacodynamics, pharmacokinetics, and clinical activityPaul G Richardson, Cathy Eng, Jill Kolesar, et al.
Analytical Chemistry|March 12, 2014
A nano ultra-performance liquid chromatography-high resolution mass spectrometry approach for global metabolomic profiling and case study on drug-resistant multiple myelomaDrew R Jones, Zhiping Wu, Dharminder Chauhan, et al.
Leukemia|March 16, 2019
Selective targeting of multiple myeloma by B cell maturation antigen (BCMA)-specific central memory CD8<sup>+</sup> cytotoxic T lymphocytes: immunotherapeutic application in vaccination and adoptive immunotherapyJooeun Bae, Mehmet Samur, Paul Richardson, et al.
Current Opinion in Hematology|September 28, 2007
Novel therapies in myelomaPatrick J Hayden, Constantine S Mitsiades, Kenneth C Anderson, et al.
Nature Clinical Practice. Oncology|May 31, 2007
Does maintenance therapy with thalidomide benefit patients with multiple myeloma?Nikhil C Munshi, Constantine S Mitsiades, Paul G Richardson, et al.
Lancet (London, England)|June 23, 2009
Multiple myelomaMarc S Raab, Klaus Podar, Iris Breitkreutz, et al.
Pageof 87